Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Gilead Sciences, Inc. (GILD) had Revenue of $7.77B for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$7.77B
Net Income	$3.05B
Cost of Goods Sold	$1.57B
Gross Profit	$6.20B
Operating Expenses	$4.44B
Operating Income	$3.33B
Non-Operating Income/Expense	$313.00M
Pre-Tax Income	$3.64B
Normalized Pre-Tax Income	$3.64B
Income after Taxes	$3.05B
Income from Continuous Operations	$3.05B
Consolidated Net Income/Loss	$3.05B
Normalized Income after Taxes	$3.05B
EBIT	$3.33B
EBITDA	$4.01B
Weighted-Average Shares Outstanding (Basic)	1.24B
Weighted-Average Shares Outstanding (Diluted)	1.25B
Earnings per Share (EPS) (Basic)	$2.46
Earnings per Share (EPS) (Diluted)	$2.43
Balance Sheet Financials
Current Assets	$17.87B
Property, Plant, and Equipment	$5.50B
Long-Term Assets	$40.66B
Total Assets	$58.53B
Current Liabilities	$12.30B
Long-Term Debt	$22.14B
Long-Term Liabilities	$24.78B
Total Liabilities	$37.08B
Common Equity	$21.46B
Tangible Shareholders Equity	$-4.83B
Shareholders Equity	$21.46B
Common Shares Outstanding	1.24B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.69B
Cash Flow from Investing Activities	$-2.96B
Cash Flow from Financial Activities	$-6.48B
Beginning Cash	$9.99B
End Cash	$7.33B
Increase/Decrease in Cash	$-2.66B
Stock-Based Compensation	$664.00M
Common Stock Dividends Paid	$-3.01B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.51
Debt to Equity Ratio	1.16
Gross Margin	79.80%
Operating Margin	42.82%
EBIT Margin	42.82%
EBITDA Margin	--
Pre-Tax Profit Margin	46.87%
Profit Margin	39.28%
Free Cash Flow	$6.33B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.88
Receiveable Turnover	1.52
Days Sales in Receivables	59.02
Return on Equity	14.22%
Return on Tangible Equity	-63.21%
Return on Assets	5.21%
Return on Investments	7.00%
Book Value Per Share	$17.28
Free Cash Flow per Share	$5.05
Operating Cash Flow per Share	$5.34

Data from Zacks Investment Research, Inc.